Source: Journal of Viral Hepatitis. Unidade: FM
Subjects: INFECÇÕES POR HIV (TERAPIA), HOSPEDEIRO IMUNOCOMPROMETIDO, HEPATITE C (TERAPIA), COMORBIDADE
ABNT
ARAÚJO, E. S. A. et al. Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients. Journal of Viral Hepatitis, v. 18, n. 2, p. e52-e60, 2011Tradução . . Disponível em: https://doi.org/10.1111/j.1365-2893.2010.01358.x. Acesso em: 03 nov. 2024.APA
Araújo, E. S. A., Dahari, H., Neumann, A. U., Cavalheiro, N. de P., Melo, C. E., Melo, E. S. de, et al. (2011). Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients. Journal of Viral Hepatitis, 18( 2), e52-e60. doi:10.1111/j.1365-2893.2010.01358.xNLM
Araújo ESA, Dahari H, Neumann AU, Cavalheiro N de P, Melo CE, Melo ES de, Layden TJ, Cotler SJ, Barone AA. Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients [Internet]. Journal of Viral Hepatitis. 2011 ; 18( 2): e52-e60.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/j.1365-2893.2010.01358.xVancouver
Araújo ESA, Dahari H, Neumann AU, Cavalheiro N de P, Melo CE, Melo ES de, Layden TJ, Cotler SJ, Barone AA. Very early prediction of response to HCV treatment with PEG-IFN-alfa-2a and ribavirin in HIV/HCV-coinfected patients [Internet]. Journal of Viral Hepatitis. 2011 ; 18( 2): e52-e60.[citado 2024 nov. 03 ] Available from: https://doi.org/10.1111/j.1365-2893.2010.01358.x